BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vos CMH, Mason NL, Kuypers KPC. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. Front Psychiatry 2021;12:724606. [PMID: 34566723 DOI: 10.3389/fpsyt.2021.724606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Nutt D, Spriggs M, Erritzoe D. Psychedelics therapeutics: What we know, what we think, and what we need to research. Neuropharmacology 2023;223:109257. [PMID: 36179919 DOI: 10.1016/j.neuropharm.2022.109257] [Reference Citation Analysis]
2 Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. Int J Mol Sci 2023;24. [PMID: 36674849 DOI: 10.3390/ijms24021329] [Reference Citation Analysis]
3 Singewald N, Sartori SB, Reif A, Holmes A. Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. Neuropharmacology 2023;226:109418. [PMID: 36623804 DOI: 10.1016/j.neuropharm.2023.109418] [Reference Citation Analysis]
4 Sapienza J, Bosia M, Spangaro M, Martini F, Agostoni G, Cuoco F, Cocchi F, Cavallaro R. Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes. Mol Psychiatry 2023;28:59-67. [PMID: 35931756 DOI: 10.1038/s41380-022-01721-5] [Reference Citation Analysis]
5 Johnston CB, Mangini M, Grob C, Anderson B. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. Am J Geriatr Psychiatry 2023;31:44-53. [PMID: 36184377 DOI: 10.1016/j.jagp.2022.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Neurosurgery 2022;Publish Ahead of Print. [DOI: 10.1227/neu.0000000000002275] [Reference Citation Analysis]
7 Maccallum CA, Lo LA, Pistawka CA, Deol JK. Therapeutic use of psilocybin: Practical considerations for dosing and administration. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1040217] [Reference Citation Analysis]
8 Grieco SF, Castrén E, Knudsen GM, Kwan AC, Olson DE, Zuo Y, Holmes TC, Xu X. Psychedelics and Neural Plasticity: Therapeutic Implications. J Neurosci 2022;42:8439-49. [PMID: 36351821 DOI: 10.1523/JNEUROSCI.1121-22.2022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vanderzwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-azu B, Tremblay M. The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03772-0] [Reference Citation Analysis]
10 Guglielmo R, Hasler G. The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder. Neuroscience & Biobehavioral Reviews 2022;142:104906. [DOI: 10.1016/j.neubiorev.2022.104906] [Reference Citation Analysis]
11 Mallaroni P, Mason NL, Kloft L, Reckweg JT, van Oorsouw K, Toennes SW, Tolle HM, Amico E, Ramaekers JG. Ritualistic use of ayahuasca enhances a shared functional connectome identity with others.. [DOI: 10.1101/2022.10.07.511268] [Reference Citation Analysis]
12 López-arnau R, Camarasa J, Carbó M, Nadal-gratacós N, Puigseslloses P, Espinosa-velasco M, Urquizu E, Escubedo E, Pubill D. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Front Psychiatry 2022;13:990405. [DOI: 10.3389/fpsyt.2022.990405] [Reference Citation Analysis]
13 Stoliker D, Egan GF, Friston KJ, Razi A, Barker E. Neural Mechanisms and Psychology of Psychedelic Ego Dissolution. Pharmacol Rev 2022;74:874-915. [DOI: 10.1124/pharmrev.121.000508] [Reference Citation Analysis]
14 Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Front Psychiatry 2022;13:917199. [DOI: 10.3389/fpsyt.2022.917199] [Reference Citation Analysis]
15 Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology 2022. [PMID: 35810199 DOI: 10.1038/s41386-022-01370-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Bosch OG, Halm S, Seifritz E. Psychedelics in the treatment of unipolar and bipolar depression. Int J Bipolar Disord 2022;10:18. [PMID: 35788817 DOI: 10.1186/s40345-022-00265-5] [Reference Citation Analysis]
17 Pöllänen E, Osika W, Stenfors CUD, Simonsson O. Classic Psychedelics and Human–Animal Relations. IJERPH 2022;19:8114. [DOI: 10.3390/ijerph19138114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Sci Rep 2022;12:11091. [PMID: 35773270 DOI: 10.1038/s41598-022-14512-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cavarra M, Falzone A, Ramaekers JG, Kuypers KPC, Mento C. Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions. Front Psychol 2022;13:887255. [PMID: 35756295 DOI: 10.3389/fpsyg.2022.887255] [Reference Citation Analysis]
20 Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology 2022. [PMID: 35729252 DOI: 10.1038/s41386-022-01361-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kirchweger B, Klein-Junior LC, Pretsch D, Chen Y, Cretton S, Gasper AL, Heyden YV, Christen P, Kirchmair J, Henriques AT, Rollinger JM. Azepine-Indole Alkaloids From Psychotria nemorosa Modulate 5-HT2A Receptors and Prevent in vivo Protein Toxicity in Transgenic Caenorhabditis elegans. Front Neurosci 2022;16:826289. [PMID: 35360162 DOI: 10.3389/fnins.2022.826289] [Reference Citation Analysis]
22 Stoliker D, Egan GF, Razi A. Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics. Front Neurosci 2022;16:827400. [DOI: 10.3389/fnins.2022.827400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Desouza LA, Benekareddy M, Fanibunda SE, Mohammad F, Janakiraman B, Ghai U, Gur T, Blendy JA, Vaidya VA. The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex. Front Mol Neurosci 2021;14:790213. [PMID: 35002622 DOI: 10.3389/fnmol.2021.790213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
25 Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. Pharmaceuticals (Basel) 2021;14:1213. [PMID: 34959614 DOI: 10.3390/ph14121213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Desouza LA, Benekareddy M, Fanibunda SE, Mohammad F, Gur T, Blendy JA, Vaidya VA. The hallucinogenic serotonin2A receptor agonist, DOI, promotes CREB-dependent gene expression of specific plasticity-associated genes in the rodent neocortex.. [DOI: 10.1101/2021.10.19.464691] [Reference Citation Analysis]